(HealthDay News) — Here are the latest clinical trials, courtesy of CenterWatch:

Acromegaly

This 12-month research study will evaluate the relationship between growth hormone (GH) levels and heart disease in people cured of acromegaly. This study investigates whether physiologic GH replacement therapy will reduce cardiovascular risk in men and women ages 18 to 75 with GH deficiency following cure of acromegaly. Research site located in Boston, Mass.

More Information

Please see http://www.centerwatch.com/patient/studies/cat327.html.

—–

companies Healthy Women Studies

Women at high risk for breast c ancer are eligible for participation in this research study. The purpose of the study is to determine if breast duct cells can provide additional information about the near-term risk of developing breast cancer when a woman is already at an elevated lifetime risk for breast cancer. Must be between ages 35-70, have intact nipples, have had a family history of breast cancer and be available for five years. Research sites located in Arlington Heights and Chicago, Ill.

More Information

Please see http://www.centerwatch.com/patient/studies/cat438.html.

—–

seo tips Generalized Anxiety Disorder (GAD)

This research study aims to explore the responsiveness of generalized anxiety disorder to an investigational medication. Treatment will be given for 12 weeks, double-blind, placebo and active comparator controlled. Participants must be between 18 and 65 years, in good health, and have symptoms consistent with a diagnosis of GAD. Research site located in Washington, DC.

More Information

Please see http://www.centerwatch.com/patient/studies/cat414.html.

—–

Copyright 2005 CenterWatch. All rights reserved.